GO:0070343 white fat cell proliferation: Progenitor Expansion, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070343 white fat cell proliferation describes the multiplication of white adipocytes by cell division, expanding the white fat cell population.
• White fat cell proliferation is driven by adipose progenitor cells (APCs) that reside in the stromal-vascular fraction and respond to local and systemic cues.
• Key regulators include CD81, which controls beige fat progenitor growth via FAK signaling, and EPAC1, which enhances brown fat growth and beige adipogenesis.
• Sympathetic neuropeptide Y (NPY) sustains thermogenic fat and protects from obesity, linking neuronal signals to fat cell proliferation.
• Lipolysis-derived linoleic acid acts as a proliferative signal for beige fat progenitor cells, coupling lipid mobilization to progenitor expansion.
• Dlgap1 negatively regulates browning of white fat cells by affecting cell proliferation and apoptosis, highlighting a brake on white fat cell expansion.
Description
White fat cell proliferation (GO:0070343) is the biological process by which white adipocytes multiply through cell division, leading to expansion of the white fat cell population. This process is central to adipose tissue plasticity and is driven largely by the proliferation and differentiation of resident adipose progenitor cells (APCs) within the stromal-vascular fraction. Understanding white fat cell proliferation is essential because it underlies both normal adipose homeostasis and pathological adipose expansion in obesity and metabolic disease. Recent single-cell lineage tracing has revealed distinct adipocyte precursor dynamics in different depots, such as skin versus inguinal fat, indicating that white fat cell proliferation is not a uniform process but is context-dependent. Moreover, the discovery that lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation links lipid mobilization directly to progenitor expansion. These findings position white fat cell proliferation as a key node where metabolic signals, neuronal inputs, and local growth factors converge to control fat mass.
white fat cell proliferation At A Glance
| GO ID | GO:0070343 |
|---|---|
| GO term | white fat cell proliferation |
| Ontology | biological_process |
| Synonym | white adipocyte proliferation; white adipose cell proliferation |
| Major function | Multiplication of white fat cells by cell division, expanding the white adipocyte population |
| Related cell type | White adipocytes and their adipose progenitor cells (APCs) |
| Key signaling context | FAK signaling, EPAC1-mediated cAMP signaling, sympathetic NPY signaling, lipolysis-derived linoleic acid |
| Physiological outcome | Adipose tissue expansion and metabolic homeostasis |
| Pathological relevance | Obesity, insulin resistance, and adipose tissue dysfunction |
What Is GO:0070343?
According to the Gene Ontology, GO:0070343 white fat cell proliferation is defined as the multiplication or reproduction of white fat cells by cell division, resulting in the expansion of their population. In practical terms, it encompasses the mitotic division of white adipocytes or their committed progenitors that increases the number of white fat cells in a depot. This process is distinct from adipocyte hypertrophy (cell enlargement) and from brown/beige adipocyte proliferation, although shared regulators exist.
Why Is white fat cell proliferation Important in Cell Biology?
White fat cell proliferation is important because it determines adipose tissue cellularity and contributes to the expansion of white adipose tissue in obesity. Unlike hypertrophy, which increases fat cell size, proliferation increases fat cell number and is driven by adipose progenitor cells that can be targeted to modulate fat mass. Dysregulated white fat cell proliferation is linked to metabolic disease, and understanding its regulators may reveal therapeutic opportunities for obesity and related disorders.
• White fat cell proliferation expands the white adipocyte population and contributes to adipose tissue cellularity.
• Adipose progenitor cells (APCs) are the main source of new white fat cells, and their dynamics differ between depots.
• CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling, showing that progenitor proliferation is metabolically important.
• EPAC1 enhances brown fat growth and beige adipogenesis, linking cAMP signaling to fat cell proliferation.
• Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat, connecting neuronal signals to fat cell proliferation.
• Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation, coupling lipid mobilization to progenitor expansion.
• Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis.
• Angiogenesis is closely associated with adipose tissue expansion in obesity, and proliferating fat cells require vascular support.
• Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis, showing that related progenitors exist in other tissues.
• Understanding white fat cell proliferation may inform strategies to modulate fat mass in metabolic disease.
What Happens During white fat cell proliferation?
Activation of adipose progenitor cells
In simple terms: Fat precursor cells wake up and get ready to divide.
White fat cell proliferation begins with the activation of adipose progenitor cells (APCs) residing in the stromal-vascular fraction of adipose tissue. Single-cell lineage tracing has shown that adipocyte precursor dynamics differ between depots, such as skin and inguinal fat, indicating that APC activation is context-dependent. These progenitors respond to local and systemic cues, including growth factors and metabolic signals, to enter the cell cycle.
Proliferative signaling through FAK and EPAC1
In simple terms: Specific molecular switches tell the precursors to multiply.
CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling, demonstrating that FAK pathway activation is required for progenitor proliferation. EPAC1, a cAMP sensor, enhances brown fat growth and beige adipogenesis, linking cAMP signaling to fat cell proliferation. These pathways provide druggable nodes for modulating white fat cell proliferation.
Metabolic and neuronal inputs
In simple terms: Nerves and fat breakdown products send growth signals.
Sympathetic neuropeptide Y (NPY) protects from obesity by sustaining thermogenic fat, connecting neuronal signals to fat cell proliferation. Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation, showing that lipid mobilization directly fuels progenitor expansion. Together, these inputs integrate whole-body metabolic state with local progenitor proliferation.
Negative regulation and apoptosis
In simple terms: Brakes exist to prevent excessive fat cell growth.
Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis, indicating that proliferation and cell death are coordinated. This balance ensures that white fat cell proliferation is not unchecked, and its disruption may contribute to adipose tissue dysfunction.
Vascular support and tissue expansion
In simple terms: New fat cells need blood vessels to grow.
Angiogenesis is closely associated with adipose tissue expansion in obesity, and proliferating fat cells require adequate vascular supply. This coupling ensures that white fat cell proliferation is matched with tissue remodeling and nutrient delivery.
Key Genes Involved in GO:0070343 white fat cell proliferation
The following genes and proteins have been experimentally implicated in white fat cell proliferation or closely related adipose progenitor proliferation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD81 | Controls beige fat progenitor cell growth via FAK signaling | Regulates energy balance and progenitor proliferation |
| EPAC1 (RAPGEF3) | Enhances brown fat growth and beige adipogenesis | cAMP sensor linking signaling to fat cell proliferation |
| NPY | Sympathetic neuropeptide that sustains thermogenic fat | Protects from obesity via fat cell proliferation |
| Dlgap1 | Negatively regulates browning of white fat cells | Affects cell proliferation and apoptosis |
| FAK (PTK2) | Mediates CD81-dependent progenitor growth signaling | Downstream effector of CD81 in fat progenitors |
| Linoleic acid (metabolite) | Lipolysis-derived signal driving beige fat progenitor proliferation | Links lipid mobilization to progenitor expansion |
| Adipose progenitor cells (APCs) | Source of new white fat cells | Depot-specific dynamics revealed by lineage tracing |
| Fibro/adipogenic progenitors (FAPs) | Resident progenitors activated by muscle injury | Related progenitor population in muscle |
| Angiogenic factors (e.g., VEGF) | Support vascularization during adipose expansion | Couples proliferation to angiogenesis in obesity |
How Is white fat cell proliferation Regulated?
White fat cell proliferation is regulated by a network of signaling pathways. CD81 controls beige fat progenitor cell growth via FAK signaling, and loss of CD81 impairs progenitor proliferation. EPAC1 enhances brown fat growth and beige adipogenesis through cAMP-mediated signaling. Sympathetic neuropeptide Y sustains thermogenic fat and protects from obesity, providing neuronal control of fat cell proliferation. Lipolysis-derived linoleic acid acts as a proliferative signal for beige fat progenitor cells, linking lipid mobilization to progenitor expansion. Dlgap1 negatively regulates browning of white fat cells by affecting cell proliferation and apoptosis, serving as a brake on white fat cell expansion. Angiogenesis is also coupled to adipose tissue expansion, ensuring vascular support for proliferating fat cells.
white fat cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD81 | Obesity and energy balance | KO and overexpression in adipocyte progenitors |
| EPAC1 (RAPGEF3) | Brown fat growth and beige adipogenesis | Knock-in and point mutation models |
| NPY | Obesity protection via thermogenic fat | KO and overexpression models |
| Dlgap1 | White fat browning and apoptosis | KO and point mutation models |
| FAK (PTK2) | Progenitor proliferation signaling | Knock-in and tagged knock-in models |
Obesity and metabolic disease
White fat cell proliferation contributes to adipose tissue expansion in obesity, and dysregulated progenitor proliferation can lead to pathological fat accumulation. CD81 controls beige fat progenitor cell growth and energy balance, and its dysfunction may impair thermogenesis and promote obesity. Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat, linking neuronal signals to fat cell proliferation.
Insulin resistance and type 2 diabetes
Adipose tissue dysfunction, including altered white fat cell proliferation, is associated with insulin resistance. EPAC1 enhances brown fat growth and beige adipogenesis, and its activity may influence systemic glucose homeostasis. Lipolysis-derived linoleic acid drives beige fat progenitor proliferation, coupling lipid flux to metabolic health.
Adipose tissue regeneration and fibrosis
Fibro/adipogenic progenitors (FAPs) are activated by muscle injury and facilitate myogenesis, indicating that related progenitor populations contribute to tissue repair. Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis, and its dysregulation may affect adipose remodeling.
From white fat cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD81 loss impair white fat cell proliferation? | CD81 knockout in adipose progenitor cells |
| Does EPAC1 activation enhance beige adipogenesis? | EPAC1 overexpression and knock-in models |
| Does NPY sustain thermogenic fat? | NPY knockout and overexpression models |
| Does Dlgap1 negatively regulate white fat browning? | Dlgap1 knockout and point mutation models |
| Does linoleic acid drive progenitor proliferation? | Knock-in of lipid-sensing pathways and overexpression |
| Do APCs differ between depots? | Lineage tracing and single-cell models |
How to Study the white fat cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and cell division | Quantifying white fat cell proliferation |
| Ki67 staining | Proliferating cells | Assessing progenitor proliferation in adipose tissue |
| Single-cell lineage tracing | Progenitor dynamics and fate | Comparing depot-specific adipocyte precursors |
| Western blotting | Protein expression and phosphorylation | Measuring FAK and cAMP pathway activation |
| Lipidomics | Lipid species and flux | Linking linoleic acid to progenitor proliferation |
| Immunofluorescence | Protein localization and tissue architecture | Visualizing proliferating cells in adipose depots |
| RNA-seq | Transcriptional changes | Identifying genes regulating white fat cell proliferation |
| Flow cytometry | Cell surface markers and sorting | Isolating adipose progenitor cells |
Lineage tracing and single-cell analysis
Comparative single-cell lineage tracing can identify distinct adipocyte precursor dynamics in different depots, such as skin and inguinal fat, revealing heterogeneity in white fat cell proliferation.
Proliferation assays
EdU/BrdU incorporation and Ki67 staining measure cell division in adipose progenitor cells and white adipocytes, allowing quantification of white fat cell proliferation.
Signaling pathway analysis
Western blotting and phospho-specific antibodies can assess FAK and cAMP pathway activation in response to CD81 or EPAC1 manipulation.
Metabolic and lipid flux measurements
Lipolysis assays and lipidomics can determine how lipolysis-derived linoleic acid influences beige fat progenitor proliferation.
How CRISPR Can Be Used to Study GO:0070343 white fat cell proliferation
Knockout
CRISPR knockout of CD81 or Dlgap1 in adipose progenitor cells can test their causal roles in white fat cell proliferation and browning.
Point Mutation
Point mutations in EPAC1 or FAK can dissect specific signaling residues required for progenitor proliferation.
Knock-in
Knock-in of fluorescent reporters or lineage tags into endogenous loci such as Cd81 or Npy enables tracking of proliferating fat cells in vivo.
Overexpression
Overexpression of EPAC1 or NPY in adipose tissue can enhance fat cell proliferation and thermogenesis, providing gain-of-function evidence.
How EDITGENE Supports white fat cell proliferation Research
Researchers studying white fat cell proliferation-related genes often need to determine whether a candidate gene is causally involved in progenitor expansion, adipogenesis, or metabolic homeostasis. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for white fat cell proliferation research.
Frequently Asked Questions About white fat cell proliferation
What is white fat cell proliferation?
White fat cell proliferation (GO:0070343) is the multiplication of white fat cells by cell division, expanding their population.
What genes are involved in white fat cell proliferation?
Key genes include CD81, EPAC1, NPY, Dlgap1, and FAK, which regulate adipose progenitor proliferation.
How is white fat cell proliferation regulated?
It is regulated by FAK signaling, cAMP signaling via EPAC1, sympathetic NPY, and lipolysis-derived linoleic acid.
What is the role of CD81 in fat cell proliferation?
CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling.
How does EPAC1 affect fat cell proliferation?
EPAC1 enhances brown fat growth and beige adipogenesis through cAMP signaling.
What is the role of NPY in fat cell proliferation?
Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat.
How does linoleic acid affect fat progenitor proliferation?
Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation.
What is the function of Dlgap1 in white fat cells?
Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis.
How can I study white fat cell proliferation in the lab?
Use EdU/BrdU incorporation, Ki67 staining, lineage tracing, and CRISPR knockout models.
What CRISPR models are available for white fat cell proliferation research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening models for genes like CD81, EPAC1, and NPY.
Conclusion
White fat cell proliferation (GO:0070343) is a fundamental biological process that expands the white adipocyte population and contributes to adipose tissue plasticity and metabolic disease. Key regulators such as CD81, EPAC1, NPY, and Dlgap1 provide mechanistic insights and potential therapeutic targets. Continued research using CRISPR models and single-cell approaches will further elucidate how white fat cell proliferation is controlled in health and disease.
References
- 1. Oguri Y et al.. 2020. CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling.. Cell 182(3):563-577.e20 PMID: 32615086
- 2. Reverte-Salisa L et al.. 2024. EPAC1 enhances brown fat growth and beige adipogenesis.. Nat Cell Biol 26(1):113-123 PMID: 38195707
- 3. Rivera-Gonzalez GC et al.. 2025. Comparative single-cell lineage tracing identifies distinct adipocyte precursor dynamics in skin and inguinal fat.. Cell Stem Cell 32(8):1267-1284.e8 PMID: 40744015
- 4. Zhu Y et al.. 2024. Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat.. Nature 634(8032):243-250 PMID: 39198648
- 5. Abe I et al.. 2022. Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation.. Dev Cell 57(23):2623-2637.e8 PMID: 36473459
- 6. Joe AW et al.. 2010. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis.. Nat Cell Biol 12(2):153-63 PMID: 20081841
- 7. Zhang J et al.. 2020. Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis.. Lipids Health Dis 19(1):39 PMID: 32169116
- 8. Nijhawans P et al.. 2020. Angiogenesis in obesity.. Biomed Pharmacother 126:110103 PMID: 32200253
